New data will be presented about Precise® Molecular Residual Disease (MRD) Test and MyRisk® Hereditary Cancer TestSALT LAKE ...
Presentation Title: The ADELA study: A Double-blind, Placebo-controlled, Randomized Phase 3 Trial of Elacestrant (ELA)+ Everolimus (EVE) Versus ELA + Placebo (PBO) in ER+/HER2-Advanced Breast Cancer ...
Dr. Courtney Morris launches Off the Court in Midland, offering cash-pay, holistic PT that bridges rehab and performance ...
The Menarini Group ("Menarini"), a leading international pharmaceutical and diagnostics company, and Stemline Therapeutics, ...
The Texas A&M Animal Welfare Judging Team brought home the national title, showcasing the dedication and expertise of ...